Introduction
The Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act) is widely regarded as one of the strictest penal statutes in India. The Act not only prescribes severe punishments for drug related offences but also imposes stringent restrictions on the grant of bail through Section 37. What makes the NDPS regime particularly distinctive is that the fate of an accused often depends upon a single factor: the quantity of the contraband allegedly recovered during investigation.
Chapter IV of the Act classifies offences and penalties on the basis of quantity. Depending upon whether the recovered substance falls within the category of “small quantity,” “intermediate quantity,” or “commercial quantity,” an accused may face drastically different legal consequences. The Central Government, through the Notification of 2001, prescribed the quantities that fall within these categories. Consequently, even a marginal increase in the quantity attributed to an accused can result in prolonged incarceration, stricter bail conditions, and substantially enhanced punishment.
A legal framework that bases punishment primarily on quantity necessarily demands precision, objectivity, and scientific reliability. If quantity determines criminal liability, the process of determining that quantity must be beyond doubt. Yet, practical experience reveals that quantity determination under the NDPS Act is often affected by issues such as improper sampling, inclusion of neutral substances, uncertainty regarding pharmaceutical formulations, absence of clear standards for liquid narcotics, and procedural non-compliance during seizure and analysis.
Over the years, both legislative reforms and judicial pronouncements have attempted to address these concerns. Standing Orders 1/88 and 1/89 sought to regulate seizure, storage, sampling, and disposal procedures. These were later supplemented by the NDPS Rules, 2022, which introduced a more structured statutory framework under Section 52A. Simultaneously, judicial decisions have significantly influenced the manner in which quantity is assessed, particularly through the shift from the “pure content theory” to the “mixture theory.”
The most significant development in this regard came through the Constitution Bench decision in Hira Singh v. Union of India[1], which held that the entire weight of a mixture, including neutral substances, must be considered while determining quantity under the NDPS Act. While the decision sought to strengthen enforcement against drug trafficking, it also reignited concerns regarding proportionality, fairness, and scientific accuracy. In many cases, punishment may now depend less on the actual narcotic content of a substance and more on the weight of neutral materials mixed with it.
These concerns become even more pronounced in cases involving liquid narcotics, medicinal formulations, and chemically diluted substances, where determining actual narcotic content presents complex scientific challenges. Despite the severe consequences attached to quantity classification, the law continues to operate without a comprehensive framework addressing these realities.
This article examines the evolution of quantity determination under the NDPS Act and critically analyses the scientific, procedural, and doctrinal challenges embedded within the present framework. It argues that the existing system, particularly after Hira Singh, risks producing disproportionate outcomes by equating neutral substances with active narcotic content. The article further contends that a more rational approach would align punishment with actual narcotic potency, scientific evidence, and constitutional principles of proportionality.
The Origins of Quantity Determination under the NDPS Regime
Section 52A was introduced into the NDPS Act in 1989 to address practical concerns relating to the handling of seized narcotic substances. Narcotic drugs are inherently vulnerable to theft, substitution, deterioration, and misuse during prolonged storage. Prior to the introduction of Section 52A, there existed no uniform procedure governing seizure, inventory preparation, sampling, storage, or disposal of contraband.
To operationalize Section 52A, the Central Government issued Standing Orders 1/88 and 1/89. These Standing Orders established procedures for classification of substances, representative sampling, preparation of inventories, maintenance of chain of custody, and eventual disposal of seized contraband. Their primary objective was to preserve evidentiary integrity while reducing the risks associated with long-term storage.
However, these Standing Orders were largely designed at a time when prosecutions predominantly involved traditional narcotic substances such as heroin, charas, and ganja. They did not adequately anticipate the increasing prevalence of pharmaceutical narcotics, liquid formulations, chemically diluted substances, and complex synthetic drugs. Consequently, significant gaps emerged in relation to the determination of quantity in cases involving liquid narcotics and mixed formulations, particularly where the active narcotic content constitutes only a small fraction of the overall substance.
From Standing Orders to Statutory Rules: The 2022 Reform
Judicial scrutiny over the years highlighted inconsistencies between the procedural safeguards contemplated under Section 52A and the practices followed during investigation. A major controversy arose because Standing Order 1/89 permitted on the spot sampling, whereas Section 52A contemplated Magistrate-certified inventories and supervision. Courts repeatedly emphasized that strict compliance with procedural safeguards assumes constitutional significance in NDPS prosecutions due to the reverse burden provisions and stringent bail restrictions contained in the Act.
The Supreme Court in Noor Aga v. State of Punjab[2] underscored the importance of strict adherence to procedural safeguards in NDPS cases, while Union of India v. Mohanlal[3] stressed the need for proper seizure, storage, and sampling procedures. In response to these concerns, the Central Government notified the NDPS Rules, 2022, which replaced the earlier Standing Orders with a more structured statutory framework.
The 2022 Rules introduced Magistrate supervised sampling, standardized inventory procedures, and clearer chain of custody requirements. These reforms aimed to strengthen evidentiary reliability and reduce procedural disputes during trial. Nevertheless, the Rules did not comprehensively address the core issue of determining quantity in cases involving liquid narcotics, pharmaceutical formulations, mixed substances, and purity variations. As a result, doctrinal uncertainty concerning quantity-based sentencing continues to persist.
From Pure Content to Mixture Theory: A Judicial Shift
The jurisprudence on quantity determination under the NDPS Act underwent a significant transformation with the transition from the “pure content theory” to the “mixture theory.” In E. Micheal Raj v. Intelligence Officer, Narcotic Control Bureau[4], the Supreme Court held that where narcotic drugs are mixed with neutral substances, only the actual narcotic content should be considered for determining whether the substance constitutes a small or commercial quantity. The Court emphasized proportionality, observing that punishment should correspond to the actual narcotic substance possessed rather than the total weight of the mixture.
This position was later overruled by the Constitution Bench in Hira Singh v. Union of India. The Court held that the entire weight of the mixture, including neutral substances, must be considered while determining quantity under the NDPS Act. The judgment relied upon the 2009 Notification introducing “Note 4,” which clarified that quantity determination applies to the whole mixture or solution.
The Court justified the mixture theory on the grounds that traffickers often dilute drugs to increase quantity and that narcotic substances are commonly consumed in mixed form. However, this approach generated serious concerns regarding proportionality. Under the mixture theory, two accused persons possessing the same quantity of actual narcotic substance may face vastly different punishments merely because one substance is diluted in a heavier neutral medium. Criminal liability, therefore, becomes dependent on the aggregate weight of the mixture rather than the actual narcotic content, potentially distorting the rational sentencing structure envisaged under the NDPS Act.
When Science Meets Law: The Challenge of Liquid Narcotics
The problem of quantity determination becomes particularly complex in cases involving liquid narcotics and pharmaceutical formulations. While the NDPS framework classifies contraband primarily in terms of weight, liquid substances are ordinarily measured by volume and often contain only small concentrations of active narcotic content suspended within a larger neutral medium. Neither the NDPS Act nor the 2022 Rules provides a clear methodology for determining whether liability should depend on total volume, aggregate weight, or actual narcotic concentration.
The issue is further complicated by scientific variability. Liquid formulations may differ in density, concentration, and composition, and improper homogenization during sampling can produce inaccurate forensic results. Representative samples may therefore fail to reflect the actual narcotic content of the entire formulation. Additionally, the law remains unclear on whether packaging materials such as bottles and containers should be excluded from quantity calculations.
These uncertainties become particularly troubling because quantity classification directly affects punishment and bail. In a legal regime that imposes severe consequences on the basis of quantity, the absence of clear scientific standards for liquid narcotics creates a serious risk of arbitrary and disproportionate outcomes.
The Constitutional Imperative of Evidentiary Certainty
The principle that “the graver the offence, the stricter the proof” is a foundational safeguard of criminal jurisprudence. Criminal law recognizes that as the severity of punishment increases, the evidentiary burden imposed on the prosecution must become more rigorous in order to minimize the possibility of arbitrary conviction and disproportionate punishment.
Under the NDPS Act, the determination of whether a substance constitutes “commercial quantity” is not a mere procedural exercise. It determines criminal liability, bail entitlement, and the quantum of sentence. Consequently, quantity determination ought to require exceptional scientific precision, procedural reliability, and evidentiary certainty.
In practice, however, there exists a contradiction between the harshness of NDPS punishments and the certainty of proof regarding quantity. Quantity assessment frequently relies on assumptions of uniformity within mixtures, representative sampling, and forensic processes that may not accurately capture the actual narcotic content. The inclusion of neutral substances after Hira Singh further aggravates this problem by making criminal liability dependent on total weight rather than actual narcotic potency.
This creates a troubling inconsistency: the more severe the punishment under the NDPS Act, the greater the possibility that quantity determination may rest upon uncertain scientific assumptions. A framework intended to impose strict penalties therefore risks undermining the evidentiary standards that are constitutionally essential in grave criminal cases.
Constitutional Dimensions of Quantity Determination: Articles 14, 21 and the Doctrine of Proportionality
The present framework governing quantity determination under the NDPS Act must also be examined through the lens of constitutional protections guaranteed under Articles 14 and 21 of the Constitution of India. Since the classification of a substance as small, intermediate, or commercial quantity directly affects punishment, bail eligibility, and personal liberty, the method adopted for determining quantity cannot remain insulated from constitutional scrutiny.
Article 14 embodies the principle of non arbitrariness and requires that legal classifications bear a rational nexus to the object sought to be achieved. The mixture theory adopted in Hira Singh seeks to curb drug trafficking by preventing offenders from escaping liability through dilution of narcotic substances. However, the approach may also produce situations where individuals possessing identical quantities of actual narcotic content are subjected to drastically different punishments solely because one substance is mixed with a larger quantity of neutral material. Such outcomes raise concerns regarding substantive equality and the rationality of quantity-based classification.
Similarly, Article 21 requires that any deprivation of personal liberty must be fair, just, and reasonable. Quantity determination under the NDPS Act is not merely a procedural exercise; it is often the decisive factor that determines the severity of punishment and the applicability of the stringent bail restrictions under Section 37. Where criminal liability is linked primarily to aggregate weight rather than actual narcotic potency, questions arise regarding the fairness of imposing severe penal consequences without adequately considering the accused’s true culpability.
The doctrine of proportionality, now firmly embedded within Indian constitutional jurisprudence, further supports a closer examination of the present framework. Proportionality requires that punishment bears a reasonable relationship to the gravity of the offence. While deterrence remains a legitimate objective of narcotics legislation, punishment should also reflect the actual harmfulness of the substance involved. A framework that treats a heavily diluted mixture in the same manner as a highly concentrated narcotic substance may, in certain circumstances, depart from this principle.
Viewed from this constitutional perspective, the debate surrounding quantity determination extends beyond statutory interpretation. It concerns the broader question of whether the existing framework sufficiently balances the State’s interest in combating drug trafficking with the constitutional commitment to fairness, equality, and proportionate punishment.
Reimagining Quantity-Based Sentencing under the NDPS Act
A more rational sentencing framework under the NDPS Act would move beyond a purely weight-based approach and instead reflect actual narcotic content and culpability. The current framework, particularly after Hira Singh, treats all mixtures alike regardless of their chemical composition, medicinal function, or actual narcotic potency. This can produce disproportionate outcomes where punishment is driven primarily by the weight of neutral material rather than the harmfulness of the narcotic substance itself.
A more balanced approach would introduce purity-sensitive sentencing, especially in cases involving pharmaceutical, liquid, medicinal, or diluted substances. Courts and investigators should be required to consider the active narcotic content revealed through forensic analysis rather than relying exclusively on aggregate weight.
The legal framework should also distinguish between different categories of neutral substances, such as consumable dilutants used in illicit street narcotics, pharmaceutical carriers employed for therapeutic purposes, and external carriers like bottles or packaging. While inclusion of consumable dilutants in trafficking cases may be justified, extending the same logic to medicinal solvents or packaging materials risks overcriminalization.
Furthermore, the NDPS Rules, 2022 should be amended to specifically regulate liquid narcotics and pharmaceutical formulations through standardized scientific protocols. Such reforms should include volumetric standards, concentration analysis, density calibration, homogenization requirements, and explicit exclusion of container weight from quantity calculations. These measures would enhance the scientific legitimacy of the NDPS regime and ensure that punishment is determined on the basis of reliable forensic evidence and proportionate liability.
Comparative International Approaches to Quantity Determination
The challenges associated with quantity determination under the NDPS Act are not unique to India. Several jurisdictions have grappled with the question of whether criminal liability should be determined by the total weight of a substance or by the actual narcotic content present within it. A comparative analysis demonstrates that many legal systems increasingly favour approaches that account for purity, potency, and the actual harmful potential of the substance rather than relying exclusively on aggregate weight.
United States: Under the federal drug sentencing framework in the United States[5] quantity remains an important factor in determining punishment. However, sentencing guidelines frequently distinguish between the weight of the controlled substance and the actual amount of active narcotic ingredient. For drugs such as methamphetamine and fentanyl, the distinction between mixture weight and actual pure drug content reflects an effort to align punishment with the seriousness of the offence and the accused’s role within the trafficking chain.
United Kingdom: The United Kingdom adopts a more nuanced approach under the Misuse of Drugs Act, 1971. While quantity is relevant, sentencing guidelines[6] also consider purity levels, the offender’s role, intended distribution, and the overall seriousness of the criminal activity. Courts are therefore not bound exclusively by weight thresholds and may differentiate between large-scale traffickers, street-level distributors, and persons possessing diluted or low-purity substances.
Canada: Canadian courts similarly recognize that quantity alone cannot be the sole indicator of culpability. Sentencing under the Controlled Drugs and Substances Act[7] takes into account purity, sophistication of operation, commercial intent, and the accused’s degree of participation. This reflects a broader commitment to individualized sentencing and proportionality.
The comparative experience demonstrates that while quantity is an important indicator of criminality, modern narcotics legislation increasingly seeks to balance effective drug control with fairness and proportionality. India’s present framework, particularly after Hira Singh, adopts a predominantly weight-based model by including neutral substances within quantity calculations. Comparative jurisprudence suggests that a more balanced model would incorporate purity, concentration, potency, intended use, and actual narcotic content alongside quantity thresholds.
Recent Judicial Developments: Section 52A, Representative Sampling and Evidentiary Safeguards
Recent judicial developments demonstrate a growing emphasis on procedural fairness and evidentiary reliability in NDPS prosecutions. Courts have increasingly recognized that where severe punishments and reverse burdens of proof are involved, strict adherence to statutory safeguards assumes heightened significance.
A major area of judicial focus has been Section 52A of the NDPS Act, which governs the preparation of inventories, photography, sampling, certification, and disposal of seized contraband. The provision seeks to preserve evidentiary integrity while reducing the practical difficulties associated with long-term storage of narcotic substances. Courts have repeatedly emphasized that the reliability of forensic evidence depends substantially upon compliance with the safeguards embedded within this provision.
The Supreme Court’s decisions in Mohanlal and subsequent cases highlighted the importance of maintaining an unbroken chain of custody and ensuring transparency during seizure and sampling. Concerns were expressed regarding the earlier practice of drawing samples at the spot of seizure without adequate judicial supervision. These concerns ultimately contributed to the introduction of the NDPS Rules, 2022, which provide a more structured mechanism for Magistrate-supervised inventories and representative sampling.
Another significant area of development relates to representative sampling. Courts have increasingly scrutinized whether the samples sent for forensic examination genuinely represent the entire seized substance. Where large numbers of packets, containers, bottles, or bundles are recovered, questions frequently arise regarding the validity of drawing samples from only a few units and extrapolating the results to the entire seizure. Judicial decisions have stressed that representative sampling must be scientifically defensible and procedurally transparent to ensure the reliability of quantity determination.
The Supreme Court in Bharat Aambale v. State of Chhattisgarh[8] clarified that every procedural irregularity under Section 52A would not automatically vitiate a prosecution. Rather, courts must examine whether the irregularity has caused actual prejudice to the accused or affected the evidentiary value of the material relied upon by the prosecution. This approach reflects a balance between procedural compliance and practical administration of criminal justice.
Recent jurisprudence also reveals a continuing judicial concern regarding the interaction between quantity determination and evidentiary safeguards. As prosecutions increasingly involve pharmaceutical preparations, synthetic drugs, and liquid formulations, courts are being called upon to assess whether existing sampling procedures adequately account for variations in concentration, composition, and narcotic content. These developments indicate that questions relating to representative sampling, forensic reliability, and procedural compliance are likely to remain central to the evolution of NDPS jurisprudence.
The emerging judicial trend suggests that quantity determination cannot be viewed in isolation. It must be assessed together with the procedural mechanisms that generate the evidence on which quantity-based liability ultimately rests. The future development of NDPS law is therefore likely to focus not only on the weight of contraband but also on the scientific and procedural integrity of the process through which that weight is established.
Conclusion
The evolution of quantity determination under the NDPS Act reveals a fundamental structural tension within the statute. The Act imposes severe punishments on the basis of quantity, yet the process of determining that quantity is frequently affected by scientific uncertainty, procedural inconsistencies, and doctrinal overbreadth.
While the NDPS Rules, 2022 improved procedures relating to seizure, sampling, and storage, they did not fully resolve the central question of how quantity should be determined in cases involving mixtures, liquid narcotics, and pharmaceutical formulations. The Constitution Bench decision in Hira Singh expanded criminal liability by including neutral substances within quantity calculations, but this approach risks producing disproportionate punishments disconnected from actual narcotic potency.
In a penal regime characterized by reverse burdens, stringent bail conditions, and mandatory minimum sentences, quantity determination cannot be treated as a routine procedural exercise. It must satisfy the highest standards of scientific accuracy and evidentiary certainty. Comparative international experience demonstrates that modern narcotics laws increasingly favour approaches that incorporate purity, concentration, and actual harmfulness alongside quantity.
Ultimately, a punishment framework based solely on aggregate weight, without adequately accounting for actual narcotic content, risks undermining the constitutional legitimacy of the NDPS regime. A scientifically informed and proportionate approach to quantity determination would better reconcile the objectives of effective narcotics control with the principles of fairness, proportionality, and criminal justice.
*Advocate, Madhya Pradesh High Court, Indore
[1] Hira Singh v. Union of India, (2020) 20 SCC 272.
[2] Noor Aga v. State of Punjab, (2008) 16 SCC 417.
[3]Union of India v. Mohanlal, (2016) 3 SCC
[4] E. Micheal Raj v. Intelligence Officer, Narcotic Control Bureau, (2008) 5 SCC 161.
[5] United States Sentencing Commission, Federal Sentencing Guidelines Manual (latest edition).
[6] Sentencing Council for England and Wales, Drug Offences Definitive Guideline.
[7] Controlled Drugs and Substances Act, S.C. 1996, c.19 (Canada).
[8]Bharat Aambale v. State of Chhattisgarh, 2025 INSC 78.